<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="review-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2016.00692</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Mini Review</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Granule-Dependent Natural Killer Cell Cytotoxicity to Fungal Pathogens</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Ogbomo</surname> <given-names>Henry</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/354963"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Mody</surname> <given-names>Christopher H.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="aff" rid="aff4"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/343344"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>The Calvin, Phoebe and Joan Snyder Institute for Chronic Diseases, University of Calgary</institution>, <addr-line>Calgary, AB</addr-line>, <country>Canada</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Microbiology, Immunology and Infectious Diseases, University of Calgary</institution>, <addr-line>Calgary, AB</addr-line>, <country>Canada</country></aff>
<aff id="aff3"><sup>3</sup><institution>Department of Physiology and Pharmacology, University of Calgary</institution>, <addr-line>Calgary, AB</addr-line>, <country>Canada</country></aff>
<aff id="aff4"><sup>4</sup><institution>Department of Internal Medicine, University of Calgary</institution>, <addr-line>Calgary, AB</addr-line>, <country>Canada</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Vincent Vieillard, Centre National de la Recherche Scientifique (CNRS), France</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Frank Momburg, German Cancer Research Center (HZ), Germany; Sophie Caillat-Zucman, French Institute of Health and Medical Research, France</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: Christopher H. Mody, <email>cmody&#x00040;ucalgary.ca</email></corresp>
<fn fn-type="other" id="fn002"><p>Specialty section: This article was submitted to NK and Innate Lymphoid Cell Biology, a section of the journal Frontiers in Immunology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>01</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>7</volume>
<elocation-id>692</elocation-id>
<history>
<date date-type="received">
<day>14</day>
<month>11</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>12</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Ogbomo and Mody.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Ogbomo and Mody</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Natural killer (NK) cells kill or inhibit the growth of a number of fungi including <italic>Cryptococcus, Candida, Aspergillus, Rhizopus</italic>, and <italic>Paracoccidioides</italic>. Although many fungi are not dangerous, invasive fungal pathogens, such as <italic>Cryptococcus neoformans</italic>, cause life-threatening disease in individuals with impaired cell-mediated immunity. While there are similarities to cell-mediated killing of tumor cells, there are also important differences. Similar to tumor killing, NK cells directly kill fungi in a receptor-mediated and cytotoxic granule-dependent manner. Unlike tumor cell killing where multiple NK cell-activating receptors cooperate and signal events that mediate cytotoxicity, only the NKp30 receptor has been described to mediate signaling events that trigger the NK cell to mobilize its cytolytic payload to the site of interaction with <italic>C. neoformans</italic> and <italic>Candida albicans</italic>, subsequently leading to granule exocytosis and fungal killing. More recently, the NKp46 receptor was reported to bind <italic>Candida glabrata</italic> adhesins Epa1, 6, and 7 and directly mediate fungal clearance. A number of unanswered questions remain. For example, is only one NK cell-activating receptor sufficient for signaling leading to fungal killing? Are the signaling pathways activated by fungi similar to those activated by tumor cells during NK cell killing? How do the cytolytic granules traffic to the site of interaction with fungi, and how does this process compare with tumor killing? Recent insights into receptor use, intracellular signaling and cytolytic granule trafficking during NK cell-mediated fungal killing will be compared to tumor killing, and the implications for therapeutic approaches will be discussed.</p>
</abstract>
<kwd-group>
<kwd>fungal cytotoxicity</kwd>
<kwd>tumor cytotoxicity</kwd>
<kwd>cytotoxic granules</kwd>
<kwd>fungal cytotoxic receptors</kwd>
<kwd>fungal cytotoxicity signaling pathways</kwd>
</kwd-group>
<contract-num rid="cn01">247301</contract-num>
<contract-sponsor id="cn01">Canadian Institutes of Health Research<named-content content-type="fundref-id">10.13039/501100000024</named-content></contract-sponsor>
<counts>
<fig-count count="2"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="60"/>
<page-count count="6"/>
<word-count count="4416"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p>In the mid-1970s, two independent groups discovered natural killer (NK) cells when they described their ability to lyse tumor cells without prior exposure (<xref ref-type="bibr" rid="B1">1</xref>, <xref ref-type="bibr" rid="B2">2</xref>). It is now well established that NK cells are also effective cytotoxic lymphocytes against fungi (<xref ref-type="bibr" rid="B3">3</xref>), in addition to their ability to lyse tumors and virus-infected tumor cells (<xref ref-type="bibr" rid="B4">4</xref>). NK cell-mediated cytotoxicity is a complex process that involves receptor-mediated binding and signaling, synapse formation, granule polarization, and granule release (<xref ref-type="bibr" rid="B5">5</xref>). For tumors, NK cell cytotoxicity is regulated by activating and inhibitory receptors that are expressed on its cell surface. Ligation of these receptors with their cognate ligands triggers downstream signaling events, and a balance in both activating and inhibiting signals tightly controls NK cell function. While there are some similarities with respect to NK cell-mediated killing of tumor cells or fungi, some important differences exist. For example, in tumor cell killing, NK cells release perforin and granzyme B as effector molecules, with the perforin-forming pores in the tumor cell membrane, thereby allowing entrance of granzyme B to activate caspases and induce target cell death (<xref ref-type="bibr" rid="B6">6</xref>). In the case of fungi killing, there is no reported use of granzyme B. Instead, NK cells release perforin to directly kill <italic>Cryptococcus neoformans</italic> and <italic>Candida albicans</italic> (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B8">8</xref>), or granulysin to directly kill <italic>Paracoccidioides brasiliensis</italic> (<xref ref-type="bibr" rid="B9">9</xref>), or IFN-gamma to directly damage <italic>Aspergillus fumigatus</italic> (<xref ref-type="bibr" rid="B10">10</xref>). NK cells also indirectly mediated fungal elimination by secreting IFN-gamma to either mediate fungicidal activity of murine peritoneal exudate cells against <italic>C. neoformans</italic> (<xref ref-type="bibr" rid="B11">11</xref>) or mediate phagocytosis of <italic>C. albicans</italic> by splenic macrophages (<xref ref-type="bibr" rid="B12">12</xref>) or secrete GM-CSF to promote neutrophil phagocytosis of <italic>C. albicans</italic> (<xref ref-type="bibr" rid="B13">13</xref>). It has also been shown that the receptor and signaling pathway used for cryptococcal killing differs from that used for tumor killing (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). This review will focus on the recent insights into activating receptor-mediated signaling and granule trafficking during NK cell killing of fungi compared to that of tumor cells.</p>
</sec>
<sec id="S2">
<title>Receptors Used by NK Cells During Killing</title>
<p>During tumor cytotoxicity, NK cells use a large number of activating receptors to mediate granule-dependent killing. Such receptors include the natural cytotoxic receptors (NCRs) such as NKp30, NKp44, and NKp46, as well as NKG2D, DNAM-1, 2B4, CD2, NKp80, CD48 and Ly9 (CD229), LFA-1, and CD16 (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B16">16</xref>&#x02013;<xref ref-type="bibr" rid="B28">28</xref>). Interestingly, no activating receptor was found to be sufficient in inducing degranulation, except when used in combination with other receptors (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B19">19</xref>). It is possible that synergy among NK receptors could be required to mediate fungal cytotoxicity as it is in tumor cytotoxicity.</p>
<p>In the context of fungal cytotoxicity, only two NK cell-activating receptors, NKp30 and NKp46, have been identified. The NKp30 receptor was identified as a fungal cytotoxic receptor when antibodies that were generated against an NK cell line, YT, inhibited fungal killing by NK cells. The NKp30 receptor directly recognized and mediated NK cell killing of <italic>C. neoformans</italic> and <italic>C. albicans</italic> (<xref ref-type="bibr" rid="B7">7</xref>) and antibody blocking or siRNA knockdown of NKp30 expression reduced fungal binding and killing (<xref ref-type="bibr" rid="B7">7</xref>). More recently, the NKp46 receptor was discovered to directly recognize and mediate killing of <italic>Candida glabrata</italic> (<xref ref-type="bibr" rid="B29">29</xref>). NKp46 was identified as a fungal cytotoxic receptor when soluble NKp46&#x02013;IgG1 fusion construct specifically bounded multiple fungal adhesins, Epa1, 6, and 7, expressed on <italic>C. glabrata</italic> and mediated killing of <italic>C. glabrata</italic> (<xref ref-type="bibr" rid="B29">29</xref>). In addition, mice deficient in NCR1 (mouse ortholog of NKp46) could not mediate clearance of systemic <italic>C. glabrata</italic> infection (<xref ref-type="bibr" rid="B29">29</xref>). Since several fungi including <italic>Cryptococcus, Candida, Aspergillus</italic>, and <italic>Coccidioides</italic> express adhesins (<xref ref-type="bibr" rid="B30">30</xref>), it is interesting to speculate that other fungal adhesins could be recognized by NK cell receptors for fungal cytotoxicity.</p>
</sec>
<sec id="S3">
<title>Signaling Pathway Activated in NK Cells During Killing</title>
<p>Signaling through NK cell-activating receptors triggers cytotoxicity (<xref ref-type="bibr" rid="B6">6</xref>). While the molecular pathways that are associated with NK cell killing of tumor target cells have been elucidated [Figure <xref ref-type="fig" rid="F1">1</xref>; (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B31">31</xref>)], the pathways associated with NK cell antifungal activity are still being elucidated (Figure <xref ref-type="fig" rid="F2">2</xref>). In tumor killing, the inhibition of phosphatidylinositol 3-kinase (PI3K) in NK cells blocked p21-activated kinase 1 (PAK1), MAPK kinase (MEK), and extracellular signal regulated kinase (Erk) activation and interfered with cytotoxic granule movement toward the target cells, thereby suppressing NK cytotoxicity (<xref ref-type="bibr" rid="B32">32</xref>). Hence, NK cell antitumor signaling follows the sequential activation of PI3K&#x02009;&#x02192;&#x02009;Rac1&#x02009;&#x02192;&#x02009;PAK1&#x02009;&#x02192;&#x02009;MEK&#x02009;&#x02192;&#x02009;Erk (<xref ref-type="bibr" rid="B6">6</xref>, <xref ref-type="bibr" rid="B32">32</xref>). A Vav1&#x02009;&#x02192;&#x02009;PLC&#x003B3;2&#x02009;&#x02192;&#x02009;Erk sequence has also been reported to mediate cytotoxicity (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B33">33</xref>) and Vav1, which is a guanine exchange factor, activated Rac1 by catalyzing GDP/GTP exchange on Rac1 (<xref ref-type="bibr" rid="B34">34</xref>). Similar to tumor killing, fungal killing, demonstrated using <italic>Cryptococcus</italic>, depended on PI3K&#x02009;&#x02192;&#x02009;Erk signaling (<xref ref-type="bibr" rid="B35">35</xref>). However, unlike tumor killing, PLC&#x003B3; was not required for cryptococcal killing (<xref ref-type="bibr" rid="B15">15</xref>). Further, in the context of tumor killing, and depending on the activating receptor involved, Src family kinases (SFKs) either directly activated PI3K, leading to Rac and Erk activation, or recruited Vav1 to activate Rac (Figure <xref ref-type="fig" rid="F1">1</xref>). While the NCRs signal through the PI3K/Rac/Erk axis (<xref ref-type="bibr" rid="B6">6</xref>), DNAM-1 and 2B4 signal through the Vav1/Rac/Erk axis (<xref ref-type="bibr" rid="B36">36</xref>), and NKG2D transmits its signal through both axes (<xref ref-type="bibr" rid="B31">31</xref>, <xref ref-type="bibr" rid="B33">33</xref>, <xref ref-type="bibr" rid="B36">36</xref>&#x02013;<xref ref-type="bibr" rid="B40">40</xref>). Similar to tumor killing, two SFKs, Fyn and Lyn, redundantly mediated NK cell anticryptococcal activity by activating PI3K and Erk1/2 (<xref ref-type="bibr" rid="B41">41</xref>). Also, SFK was required to form NK cell-cryptococcal conjugates (<xref ref-type="bibr" rid="B15">15</xref>), and NKp30 was required for NK cell&#x02013;fungal conjugate formation and PI3K&#x02013;Erk signaling (<xref ref-type="bibr" rid="B7">7</xref>), making it likely that NKp30 activated SFK. Unlike in tumor killing where Rac is activated by SFK and is downstream of PI3K, both Rac and SFK were found not to activate each other, but both were essential for PI3K activation in NK cell-mediated killing of <italic>Cryptococcus</italic> (<xref ref-type="bibr" rid="B15">15</xref>). In fact, Rac was found to be upstream of PI3K and was required for the activation of the PI3K&#x02009;&#x02192;&#x02009;Erk signaling pathway during NK cell antifungal activity (<xref ref-type="bibr" rid="B15">15</xref>), thereby suggesting two separate pathways for PI3K activation (Figure <xref ref-type="fig" rid="F2">2</xref>). This interesting finding that Rac is upstream of PI3K needs to be confirmed by others. Ultimately, in tumor and cryptococcal killing, all pathways converged at Erk to mediate granule polarization and exocytosis, resulting in target cell death. The signaling pathway activated by the other known activating receptor for fungi cytotoxicity, NKp46, remains to be identified, and the signaling pathway involved in rearming of fungal cytotoxicity also remains to be investigated (<xref ref-type="bibr" rid="B42">42</xref>).</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p><bold>Natural killer (NK) cell/tumor cytotoxicity pathway</bold>. Following receptor&#x02013;ligand interaction, NK cell receptors initiate multiple signaling cascades. While the natural cytotoxic receptors (NKp30, NKp44, and NKp46) signal through Src family kinase (SFK) to activate PI3K/Rac/Erk pathway, DNAM-1 and 2B4 signal SFK to activate Rac/Erk pathway, thereby leading to cytotoxicity.</p></caption>
<graphic xlink:href="fimmu-07-00692-g001.tif"/>
</fig>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p><bold>Natural killer (NK) cell/<italic>Cryptococcus</italic> cytotoxicity pathway</bold>. Following recognition of cryptococcal capsule and cell wall component by NK cell-activating receptors such as NKp30, receptor binding signals both Src family kinase (SFK) and Rac to activate PI3K/Erk, leading to cytotoxicity.</p></caption>
<graphic xlink:href="fimmu-07-00692-g002.tif"/>
</fig>
<p>Tumor cells express several activating ligands on their surface to ligate NK cell-activating receptors, thereby resulting in multiple activating signaling pathways that contribute to cytotoxicity. For example, NKG2D binds the ULBP ligands, DNAM-1 binds CD112 and CD155, 2B4 binds CD48, and NKp30 binds B7-H6 (<xref ref-type="bibr" rid="B43">43</xref>). To date, the only known activating fungal ligands are three adhesins, Epa1, 6, and 7, of <italic>C. glabrata</italic>, which bind to NKp46 (<xref ref-type="bibr" rid="B29">29</xref>). Thus, whether there is coordination of signaling from multiple activating receptors expressed on NK cells to mediate fungi cytotoxicity remains an unanswered question.</p>
</sec>
<sec id="S4">
<title>Cytotoxic Granule Trafficking</title>
<p>In response to tumor cells, coordinated signaling through different NK cell receptors and signaling molecules leads to polarization of cytotoxic granules toward the NK immune synapse (NKIS) formed with the target cell (<xref ref-type="bibr" rid="B44">44</xref>). The polarization of cytotoxic granules to the NKIS has been described in a sequential order. Upon conjugate formation with the target cell, the engagement of LFA-1 led to Vav1 activation (<xref ref-type="bibr" rid="B45">45</xref>). This in turn led to the polymerization and recruitment of filamentous actin (F-actin) to the NKIS (<xref ref-type="bibr" rid="B46">46</xref>). Dynein, a minus-end directed motor, rapidly moved granules along microtubules to converge on the microtubule-organizing center (MTOC) (<xref ref-type="bibr" rid="B47">47</xref>), followed by the polarization of the MTOC, together with the converged granules, to the NKIS (<xref ref-type="bibr" rid="B48">48</xref>). This process was mediated by kinesin-1, a plus-end motor that moves granules in the opposite direction, away from the MTOC (<xref ref-type="bibr" rid="B48">48</xref>). Although it is not clear how a kinesin would mediate MTOC movement to the NK cell synapse, in T cell cytotoxicity, the distal microtubule was tethered at the immune synapse and the MTOC was reeled in to the synapse by a dynein motor (<xref ref-type="bibr" rid="B49">49</xref>). Also, in T cell-mediated killing, microtubules linked the MTOC to the target contact site and the MTOC was progressively pulled to the contact site by a microtubule sliding mechanism (<xref ref-type="bibr" rid="B50">50</xref>). The MTOC movement resulted from the vector sum of tension on multiple microtubules (<xref ref-type="bibr" rid="B50">50</xref>). Following polarization, the lytic granules associated with myosin IIA, which enabled their interaction with F-actin and final transit through the actin-rich synapse to join the NK cell membrane (<xref ref-type="bibr" rid="B51">51</xref>). The contents of the cytolytic granules were then secreted directly toward the target cell through a pervasive F-actin network at the NKIS (<xref ref-type="bibr" rid="B52">52</xref>). While SFK signal mediated the rapid convergence of cytolytic granules to the MTOC without the involvement of PI3K, MEK, or PLC&#x003B3; (<xref ref-type="bibr" rid="B53">53</xref>), PI3K&#x02013;Erk signal was required for the polarization of the MTOC and converged cytolytic granules to the NKIS (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B44">44</xref>).</p>
<p>We are only beginning to understand the mechanisms by which cytotoxic granules traffic during fungal killing. Cytotoxic granule trafficking during NK cell cytotoxicity of <italic>Cryptococcus</italic> was different from that of tumors, especially because NK cells did not require LFA-1 in the process, even though the &#x003B2;2 chain of LFA-1 bound to cryptococcal capsular components GXM and GalXM (<xref ref-type="bibr" rid="B14">14</xref>). Instead, NK cells used NKp30 to bind <italic>Cryptococcus</italic> and <italic>C. albicans</italic>, mediate microbial synapse formation, and signal PI3K&#x02013;Erk to release perforin granules (<xref ref-type="bibr" rid="B7">7</xref>). Also the SFKs, Fyn and Lyn, redundantly mediated NK cell anticryptococcal activity by activating PI3K and Erk, which in turn polarized perforin-containing granules to the synapse (<xref ref-type="bibr" rid="B41">41</xref>). Furthermore, MTOC polarization toward the binding site with <italic>Cryptococcus</italic> was required for cryptococcal killing (<xref ref-type="bibr" rid="B54">54</xref>). It remains unknown whether a dynein is required for convergence of granules to the MTOC or whether a kinesin is required for polarization in response to fungi.</p>
</sec>
<sec id="S5">
<title>Implication for Therapeutic Approaches</title>
<p>Understanding the receptors used and signaling pathways activated during NK cell function may lead to therapeutic opportunities. For example, compared to healthy adults, NK cells from HIV-infected patients had diminished expression of NKp30 (<xref ref-type="bibr" rid="B7">7</xref>), defective binding, reduced perforin content, defective perforin-containing granule polarization (<xref ref-type="bibr" rid="B55">55</xref>), reduced perforin release in response to <italic>Cryptococcus</italic>, and reduced cryptococcal killing (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B55">55</xref>). Interestingly, treatment of NK cells from HIV-infected patients with IL-12 reversed these multiple defects (<xref ref-type="bibr" rid="B7">7</xref>, <xref ref-type="bibr" rid="B55">55</xref>). Since a percentage of HIV-infected patients are subclinically infected with <italic>C. neoformans</italic> (<xref ref-type="bibr" rid="B56">56</xref>), treatment with IL-12, or similar agent, could reduce or eliminate this complication. Another example is the development of pulmonary cryptococcosis and cryptococcal meningitis in patients with Crohn&#x02019;s disease or autoimmune hepatitis that were treated with the purine analog, azathioprine (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>). Azathioprine prevented Rac1 activation by blocking GTP binding to Rac1 (<xref ref-type="bibr" rid="B59">59</xref>, <xref ref-type="bibr" rid="B60">60</xref>), and Rac1 activation in NK cells is required for NK cell cytotoxicity of tumors (<xref ref-type="bibr" rid="B32">32</xref>) and <italic>Cryptococcus</italic> (<xref ref-type="bibr" rid="B15">15</xref>). Thus, the increased susceptibility to <italic>Cryptococcus</italic> in patients with Crohn&#x02019;s disease and autoimmune hepatitis that are treated with azathioprine may in part be due to the defective NK cell function resulting from azathioprine-induced blockade of the Rac1&#x02009;&#x02192;&#x02009;PI3K&#x02009;&#x02192;&#x02009;Erk cytotoxicity pathway.</p>
</sec>
<sec id="S6">
<title>Concluding Remarks</title>
<p>Fungi, like tumors, are susceptible to NK cell killing. While NK cells use multiple receptors to recognize and kill tumor cells (<xref ref-type="bibr" rid="B16">16</xref>), they use NKp30 to recognize and kill <italic>C. neoformans</italic> and <italic>C. albicans</italic> (<xref ref-type="bibr" rid="B7">7</xref>), and use NKp46 to kill <italic>C. glabrata</italic> (<xref ref-type="bibr" rid="B29">29</xref>). The paradigm in tumor cytotoxicity is that NK cells use multiple activating receptors to recognize tumor targets and the multiple NK cell-activating receptors cooperate to mediate tumor cytotoxicity. Interestingly, several fungi express multiple pattern-associated molecular patterns including adhesins (<xref ref-type="bibr" rid="B30">30</xref>), and NK cells used NKp46 to recognize the fungal adhesins Epa1, 6, and 7, which were expressed on <italic>C. glabrata</italic> (<xref ref-type="bibr" rid="B30">30</xref>). Further studies are needed to delineate other NK-activating receptors that could mediate fungal killing and to investigate whether cooperative recognition by multiple NK cell-activating receptors is required to mediate fungal cytotoxicity.</p>
</sec>
<sec id="S7" sec-type="author-contributor">
<title>Author Contributions</title>
<p>All the authors listed have made substantial, direct, and intellectual contribution to the work and approved it for publication.</p>
</sec>
<sec id="S8">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<sec id="S9">
<title>Funding</title>
<p>This work was supported by grants from the Canadian Institute for Health Research (CIHR 365812 to CM), and the Jessie Bowden Lloyd Professorship in Immunology (CM).</p>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kiessling</surname> <given-names>R</given-names></name> <name><surname>Klein</surname> <given-names>E</given-names></name> <name><surname>Wigzell</surname> <given-names>H</given-names></name></person-group>. <article-title>&#x0201C;Natural&#x0201D; killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype</article-title>. <source>Eur J Immunol</source> (<year>1975</year>) <volume>5</volume>:<fpage>112</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1002/eji.1830050208</pub-id></citation></ref>
<ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Herberman</surname> <given-names>RB</given-names></name> <name><surname>Nunn</surname> <given-names>ME</given-names></name> <name><surname>Lavrin</surname> <given-names>DH</given-names></name></person-group>. <article-title>Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic acid allogeneic tumors. I. Distribution of reactivity and specificity</article-title>. <source>Int J Cancer</source> (<year>1975</year>) <volume>16</volume>:<fpage>216</fpage>&#x02013;<lpage>29</lpage>.<pub-id pub-id-type="doi">10.1002/ijc.2910160205</pub-id><pub-id pub-id-type="pmid">50294</pub-id></citation></ref>
<ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname> <given-names>S</given-names></name> <name><surname>Zimmermann</surname> <given-names>SY</given-names></name> <name><surname>Tramsen</surname> <given-names>L</given-names></name> <name><surname>Koehl</surname> <given-names>U</given-names></name> <name><surname>Lehrnbecher</surname> <given-names>T</given-names></name></person-group>. <article-title>Natural killer cells and antifungal host response</article-title>. <source>Clin Vaccine Immunol</source> (<year>2013</year>) <volume>20</volume>:<fpage>452</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1128/CVI.00606-12</pub-id><pub-id pub-id-type="pmid">23365210</pub-id></citation></ref>
<ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moretta</surname> <given-names>A</given-names></name> <name><surname>Marcenaro</surname> <given-names>E</given-names></name> <name><surname>Parolini</surname> <given-names>S</given-names></name> <name><surname>Ferlazzo</surname> <given-names>G</given-names></name> <name><surname>Moretta</surname> <given-names>L</given-names></name></person-group>. <article-title>NK cells at the interface between innate and adaptive immunity</article-title>. <source>Cell Death Differ</source> (<year>2008</year>) <volume>15</volume>:<fpage>226</fpage>&#x02013;<lpage>33</lpage>.<pub-id pub-id-type="doi">10.1038/sj.cdd.4402170</pub-id><pub-id pub-id-type="pmid">17541426</pub-id></citation></ref>
<ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bryceson</surname> <given-names>YT</given-names></name> <name><surname>March</surname> <given-names>ME</given-names></name> <name><surname>Barber</surname> <given-names>DF</given-names></name> <name><surname>Ljunggren</surname> <given-names>HG</given-names></name> <name><surname>Long</surname> <given-names>EO</given-names></name></person-group>. <article-title>Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>202</volume>:<fpage>1001</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20051143</pub-id><pub-id pub-id-type="pmid">16203869</pub-id></citation></ref>
<ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Djeu</surname> <given-names>JY</given-names></name> <name><surname>Jiang</surname> <given-names>K</given-names></name> <name><surname>Wei</surname> <given-names>S</given-names></name></person-group>. <article-title>A view to a kill: signals triggering cytotoxicity</article-title>. <source>Clin Cancer Res</source> (<year>2002</year>) <volume>8</volume>:<fpage>636</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">11895890</pub-id></citation></ref>
<ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Li</surname> <given-names>SS</given-names></name> <name><surname>Kyei</surname> <given-names>SK</given-names></name> <name><surname>Timm-McCann</surname> <given-names>M</given-names></name> <name><surname>Ogbomo</surname> <given-names>H</given-names></name> <name><surname>Jones</surname> <given-names>GJ</given-names></name> <name><surname>Shi</surname> <given-names>M</given-names></name> <etal/></person-group> <article-title>The NK receptor NKp30 mediates direct fungal recognition and killing and is diminished in NK cells from HIV-infected patients</article-title>. <source>Cell Host Microbe</source> (<year>2013</year>) <volume>14</volume>:<fpage>387</fpage>&#x02013;<lpage>97</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2013.09.007</pub-id><pub-id pub-id-type="pmid">24139398</pub-id></citation></ref>
<ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Voigt</surname> <given-names>J</given-names></name> <name><surname>Hunniger</surname> <given-names>K</given-names></name> <name><surname>Bouzani</surname> <given-names>M</given-names></name> <name><surname>Jacobsen</surname> <given-names>ID</given-names></name> <name><surname>Barz</surname> <given-names>D</given-names></name> <name><surname>Hube</surname> <given-names>B</given-names></name> <etal/></person-group> <article-title>Human natural killer cells acting as phagocytes against <italic>Candida albicans</italic> and mounting an inflammatory response that modulates neutrophil antifungal activity</article-title>. <source>J Infect Dis</source> (<year>2014</year>) <volume>209</volume>:<fpage>616</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jit574</pub-id><pub-id pub-id-type="pmid">24163416</pub-id></citation></ref>
<ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Longhi</surname> <given-names>LN</given-names></name> <name><surname>da Silva</surname> <given-names>RM</given-names></name> <name><surname>Fornazim</surname> <given-names>MC</given-names></name> <name><surname>Spago</surname> <given-names>MC</given-names></name> <name><surname>de Oliveira</surname> <given-names>RT</given-names></name> <name><surname>Nowill</surname> <given-names>AE</given-names></name> <etal/></person-group> <article-title>Phenotypic and functional characterization of NK cells in human immune response against the dimorphic fungus <italic>Paracoccidioides brasiliensis</italic></article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>189</volume>:<fpage>935</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1102563</pub-id><pub-id pub-id-type="pmid">22723518</pub-id></citation></ref>
<ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bouzani</surname> <given-names>M</given-names></name> <name><surname>Ok</surname> <given-names>M</given-names></name> <name><surname>McCormick</surname> <given-names>A</given-names></name> <name><surname>Ebel</surname> <given-names>F</given-names></name> <name><surname>Kurzai</surname> <given-names>O</given-names></name> <name><surname>Morton</surname> <given-names>CO</given-names></name> <etal/></person-group> <article-title>Human NK cells display important antifungal activity against <italic>Aspergillus fumigatus</italic>, which is directly mediated by IFN-gamma release</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>:<fpage>1369</fpage>&#x02013;<lpage>76</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1003593</pub-id></citation></ref>
<ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>T</given-names></name> <name><surname>Kawakami</surname> <given-names>K</given-names></name> <name><surname>Qureshi</surname> <given-names>MH</given-names></name> <name><surname>Okamura</surname> <given-names>H</given-names></name> <name><surname>Kurimoto</surname> <given-names>M</given-names></name> <name><surname>Saito</surname> <given-names>A</given-names></name></person-group>. <article-title>Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against <italic>Cryptococcus neoformans</italic> through production of gamma interferon by natural killer cells</article-title>. <source>Infect Immun</source> (<year>1997</year>) <volume>65</volume>:<fpage>3594</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="pmid">9284124</pub-id></citation></ref>
<ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Algarra</surname> <given-names>I</given-names></name> <name><surname>Ortega</surname> <given-names>E</given-names></name> <name><surname>Serrano</surname> <given-names>MJ</given-names></name> <name><surname>Alvarez de Cienfuegos</surname> <given-names>G</given-names></name> <name><surname>Gaforio</surname> <given-names>JJ</given-names></name></person-group>. <article-title>Suppression of splenic macrophage <italic>Candida albicans</italic> phagocytosis following in vivo depletion of natural killer cells in immunocompetent BALB/c mice and T-cell-deficient nude mice</article-title>. <source>FEMS Immunol Med Microbiol</source> (<year>2002</year>) <volume>33</volume>:<fpage>159</fpage>&#x02013;<lpage>63</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-695X.2002.tb00586.x</pub-id><pub-id pub-id-type="pmid">12110477</pub-id></citation></ref>
<ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bar</surname> <given-names>E</given-names></name> <name><surname>Whitney</surname> <given-names>PG</given-names></name> <name><surname>Moor</surname> <given-names>K</given-names></name> <name><surname>Reis e Sousa</surname> <given-names>C</given-names></name> <name><surname>LeibundGut-Landmann</surname> <given-names>S</given-names></name></person-group>. <article-title>IL-17 regulates systemic fungal immunity by controlling the functional competence of NK cells</article-title>. <source>Immunity</source> (<year>2014</year>) <volume>40</volume>:<fpage>117</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2013.12.002</pub-id><pub-id pub-id-type="pmid">24412614</pub-id></citation></ref>
<ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname> <given-names>GJ</given-names></name> <name><surname>Wiseman</surname> <given-names>JC</given-names></name> <name><surname>Marr</surname> <given-names>KJ</given-names></name> <name><surname>Wei</surname> <given-names>S</given-names></name> <name><surname>Djeu</surname> <given-names>JY</given-names></name> <name><surname>Mody</surname> <given-names>CH</given-names></name></person-group>. <article-title>In contrast to anti-tumor activity, YT cell and primary NK cell cytotoxicity for <italic>Cryptococcus neoformans</italic> bypasses LFA-1</article-title>. <source>Int Immunol</source> (<year>2009</year>) <volume>21</volume>:<fpage>423</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1093/intimm/dxp010</pub-id><pub-id pub-id-type="pmid">19261694</pub-id></citation></ref>
<ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiang</surname> <given-names>RF</given-names></name> <name><surname>Stack</surname> <given-names>D</given-names></name> <name><surname>Huston</surname> <given-names>SM</given-names></name> <name><surname>Li</surname> <given-names>SS</given-names></name> <name><surname>Ogbomo</surname> <given-names>H</given-names></name> <name><surname>Kyei</surname> <given-names>SK</given-names></name> <etal/></person-group> <article-title>Ras-related C3 botulinum toxin substrate (Rac) and Src family kinases (SFK) are proximal and essential for phosphatidylinositol 3-kinase (PI3K) activation in natural killer (NK) cell-mediated direct cytotoxicity against <italic>Cryptococcus neoformans</italic></article-title>. <source>J Biol Chem</source> (<year>2016</year>) <volume>291</volume>:<fpage>6912</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M115.681544</pub-id><pub-id pub-id-type="pmid">26867574</pub-id></citation></ref>
<ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moretta</surname> <given-names>A</given-names></name> <name><surname>Bottino</surname> <given-names>C</given-names></name> <name><surname>Vitale</surname> <given-names>M</given-names></name> <name><surname>Pende</surname> <given-names>D</given-names></name> <name><surname>Cantoni</surname> <given-names>C</given-names></name> <name><surname>Mingari</surname> <given-names>MC</given-names></name> <etal/></person-group> <article-title>Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis</article-title>. <source>Annu Rev Immunol</source> (<year>2001</year>) <volume>19</volume>:<fpage>197</fpage>&#x02013;<lpage>223</lpage>.<pub-id pub-id-type="doi">10.1146/annurev.immunol.19.1.197</pub-id><pub-id pub-id-type="pmid">11244035</pub-id></citation></ref>
<ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bryceson</surname> <given-names>YT</given-names></name> <name><surname>Ljunggren</surname> <given-names>HG</given-names></name> <name><surname>Long</surname> <given-names>EO</given-names></name></person-group>. <article-title>Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors</article-title>. <source>Blood</source> (<year>2009</year>) <volume>114</volume>:<fpage>2657</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2009-01-201632</pub-id><pub-id pub-id-type="pmid">19628705</pub-id></citation></ref>
<ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bryceson</surname> <given-names>YT</given-names></name> <name><surname>March</surname> <given-names>ME</given-names></name> <name><surname>Ljunggren</surname> <given-names>HG</given-names></name> <name><surname>Long</surname> <given-names>EO</given-names></name></person-group>. <article-title>Activation, coactivation, and costimulation of resting human natural killer cells</article-title>. <source>Immunol Rev</source> (<year>2006</year>) <volume>214</volume>:<fpage>73</fpage>&#x02013;<lpage>91</lpage>.<pub-id pub-id-type="doi">10.1111/j.1600-065X.2006.00457.x</pub-id><pub-id pub-id-type="pmid">17100877</pub-id></citation></ref>
<ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bryceson</surname> <given-names>YT</given-names></name> <name><surname>March</surname> <given-names>ME</given-names></name> <name><surname>Ljunggren</surname> <given-names>HG</given-names></name> <name><surname>Long</surname> <given-names>EO</given-names></name></person-group>. <article-title>Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion</article-title>. <source>Blood</source> (<year>2006</year>) <volume>107</volume>:<fpage>159</fpage>&#x02013;<lpage>66</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2005-04-1351</pub-id><pub-id pub-id-type="pmid">16150947</pub-id></citation></ref>
<ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Castriconi</surname> <given-names>R</given-names></name> <name><surname>Dondero</surname> <given-names>A</given-names></name> <name><surname>Corrias</surname> <given-names>MV</given-names></name> <name><surname>Lanino</surname> <given-names>E</given-names></name> <name><surname>Pende</surname> <given-names>D</given-names></name> <name><surname>Moretta</surname> <given-names>L</given-names></name> <etal/></person-group> <article-title>Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction</article-title>. <source>Cancer Res</source> (<year>2004</year>) <volume>64</volume>:<fpage>9180</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1158/0008-5472.CAN-04-2682</pub-id><pub-id pub-id-type="pmid">15604290</pub-id></citation></ref>
<ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glasner</surname> <given-names>A</given-names></name> <name><surname>Ghadially</surname> <given-names>H</given-names></name> <name><surname>Gur</surname> <given-names>C</given-names></name> <name><surname>Stanietsky</surname> <given-names>N</given-names></name> <name><surname>Tsukerman</surname> <given-names>P</given-names></name> <name><surname>Enk</surname> <given-names>J</given-names></name> <etal/></person-group> <article-title>Recognition and prevention of tumor metastasis by the NK receptor NKp46/NCR1</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>188</volume>:<fpage>2509</fpage>&#x02013;<lpage>15</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1102461</pub-id><pub-id pub-id-type="pmid">22308311</pub-id></citation></ref>
<ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Guerra</surname> <given-names>N</given-names></name> <name><surname>Tan</surname> <given-names>YX</given-names></name> <name><surname>Joncker</surname> <given-names>NT</given-names></name> <name><surname>Choy</surname> <given-names>A</given-names></name> <name><surname>Gallardo</surname> <given-names>F</given-names></name> <name><surname>Xiong</surname> <given-names>N</given-names></name> <etal/></person-group> <article-title>NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy</article-title>. <source>Immunity</source> (<year>2008</year>) <volume>28</volume>:<fpage>571</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2008.02.016</pub-id><pub-id pub-id-type="pmid">18394936</pub-id></citation></ref>
<ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Halfteck</surname> <given-names>GG</given-names></name> <name><surname>Elboim</surname> <given-names>M</given-names></name> <name><surname>Gur</surname> <given-names>C</given-names></name> <name><surname>Achdout</surname> <given-names>H</given-names></name> <name><surname>Ghadially</surname> <given-names>H</given-names></name> <name><surname>Mandelboim</surname> <given-names>O</given-names></name></person-group>. <article-title>Enhanced in vivo growth of lymphoma tumors in the absence of the NK-activating receptor NKp46/NCR1</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>182</volume>:<fpage>2221</fpage>&#x02013;<lpage>30</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0801878</pub-id><pub-id pub-id-type="pmid">19201876</pub-id></citation></ref>
<ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Iguchi-Manaka</surname> <given-names>A</given-names></name> <name><surname>Kai</surname> <given-names>H</given-names></name> <name><surname>Yamashita</surname> <given-names>Y</given-names></name> <name><surname>Shibata</surname> <given-names>K</given-names></name> <name><surname>Tahara-Hanaoka</surname> <given-names>S</given-names></name> <name><surname>Honda</surname> <given-names>S</given-names></name> <etal/></person-group> <article-title>Accelerated tumor growth in mice deficient in DNAM-1 receptor</article-title>. <source>J Exp Med</source> (<year>2008</year>) <volume>205</volume>:<fpage>2959</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20081611</pub-id><pub-id pub-id-type="pmid">19029379</pub-id></citation></ref>
<ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pende</surname> <given-names>D</given-names></name> <name><surname>Cantoni</surname> <given-names>C</given-names></name> <name><surname>Rivera</surname> <given-names>P</given-names></name> <name><surname>Vitale</surname> <given-names>M</given-names></name> <name><surname>Castriconi</surname> <given-names>R</given-names></name> <name><surname>Marcenaro</surname> <given-names>S</given-names></name> <etal/></person-group> <article-title>Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin</article-title>. <source>Eur J Immunol</source> (<year>2001</year>) <volume>31</volume>:<fpage>1076</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1002/1521-4141(200104)31:4&#x0003C;1076::AID-IMMU1076&#x0003E;3.0.CO;2-Y</pub-id><pub-id pub-id-type="pmid">11298332</pub-id></citation></ref>
<ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sivori</surname> <given-names>S</given-names></name> <name><surname>Parolini</surname> <given-names>S</given-names></name> <name><surname>Marcenaro</surname> <given-names>E</given-names></name> <name><surname>Castriconi</surname> <given-names>R</given-names></name> <name><surname>Pende</surname> <given-names>D</given-names></name> <name><surname>Millo</surname> <given-names>R</given-names></name> <etal/></person-group> <article-title>Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines</article-title>. <source>J Neuroimmunol</source> (<year>2000</year>) <volume>107</volume>:<fpage>220</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1016/S0165-5728(00)00221-6</pub-id><pub-id pub-id-type="pmid">10854660</pub-id></citation></ref>
<ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname> <given-names>MJ</given-names></name> <name><surname>Swann</surname> <given-names>J</given-names></name> <name><surname>Cretney</surname> <given-names>E</given-names></name> <name><surname>Zerafa</surname> <given-names>N</given-names></name> <name><surname>Yokoyama</surname> <given-names>WM</given-names></name> <name><surname>Hayakawa</surname> <given-names>Y</given-names></name></person-group>. <article-title>NKG2D function protects the host from tumor initiation</article-title>. <source>J Exp Med</source> (<year>2005</year>) <volume>202</volume>:<fpage>583</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20050994</pub-id><pub-id pub-id-type="pmid">16129707</pub-id></citation></ref>
<ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alari-Pahissa</surname> <given-names>E</given-names></name> <name><surname>Grandclement</surname> <given-names>C</given-names></name> <name><surname>Jeevan-Raj</surname> <given-names>B</given-names></name> <name><surname>Leclercq</surname> <given-names>G</given-names></name> <name><surname>Veillette</surname> <given-names>A</given-names></name> <name><surname>Held</surname> <given-names>W</given-names></name></person-group>. <article-title>Activation by SLAM family receptors contributes to NK cell mediated &#x0201C;missing-self&#x0201D; recognition</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0153236</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0153236</pub-id></citation></ref>
<ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vitenshtein</surname> <given-names>A</given-names></name> <name><surname>Charpak-Amikam</surname> <given-names>Y</given-names></name> <name><surname>Yamin</surname> <given-names>R</given-names></name> <name><surname>Bauman</surname> <given-names>Y</given-names></name> <name><surname>Isaacson</surname> <given-names>B</given-names></name> <name><surname>Stein</surname> <given-names>N</given-names></name> <etal/></person-group> <article-title>NK cell recognition of <italic>Candida glabrata</italic> through binding of NKp46 and NCR1 to fungal ligands Epa1, Epa6, and Epa7</article-title>. <source>Cell Host Microbe</source> (<year>2016</year>) <volume>20</volume>:<fpage>527</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1016/j.chom.2016.09.008</pub-id></citation></ref>
<ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Groot</surname> <given-names>PW</given-names></name> <name><surname>Bader</surname> <given-names>O</given-names></name> <name><surname>de Boer</surname> <given-names>AD</given-names></name> <name><surname>Weig</surname> <given-names>M</given-names></name> <name><surname>Chauhan</surname> <given-names>N</given-names></name></person-group>. <article-title>Adhesins in human fungal pathogens: glue with plenty of stick</article-title>. <source>Eukaryot Cell</source> (<year>2013</year>) <volume>12</volume>:<fpage>470</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1128/EC.00364-12</pub-id><pub-id pub-id-type="pmid">23397570</pub-id></citation></ref>
<ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Long</surname> <given-names>EO</given-names></name> <name><surname>Kim</surname> <given-names>HS</given-names></name> <name><surname>Liu</surname> <given-names>D</given-names></name> <name><surname>Peterson</surname> <given-names>ME</given-names></name> <name><surname>Rajagopalan</surname> <given-names>S</given-names></name></person-group>. <article-title>Controlling natural killer cell responses: integration of signals for activation and inhibition</article-title>. <source>Annu Rev Immunol</source> (<year>2013</year>) <volume>31</volume>:<fpage>227</fpage>&#x02013;<lpage>58</lpage>.<pub-id pub-id-type="doi">10.1146/annurev-immunol-020711-075005</pub-id><pub-id pub-id-type="pmid">23516982</pub-id></citation></ref>
<ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jiang</surname> <given-names>K</given-names></name> <name><surname>Zhong</surname> <given-names>B</given-names></name> <name><surname>Gilvary</surname> <given-names>DL</given-names></name> <name><surname>Corliss</surname> <given-names>BC</given-names></name> <name><surname>Hong-Geller</surname> <given-names>E</given-names></name> <name><surname>Wei</surname> <given-names>S</given-names></name> <etal/></person-group> <article-title>Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells</article-title>. <source>Nat Immunol</source> (<year>2000</year>) <volume>1</volume>:<fpage>419</fpage>&#x02013;<lpage>25</lpage>.<pub-id pub-id-type="doi">10.1038/80859</pub-id><pub-id pub-id-type="pmid">11062502</pub-id></citation></ref>
<ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname> <given-names>HS</given-names></name> <name><surname>Das</surname> <given-names>A</given-names></name> <name><surname>Gross</surname> <given-names>CC</given-names></name> <name><surname>Bryceson</surname> <given-names>YT</given-names></name> <name><surname>Long</surname> <given-names>EO</given-names></name></person-group>. <article-title>Synergistic signals for natural cytotoxicity are required to overcome inhibition by c-Cbl ubiquitin ligase</article-title>. <source>Immunity</source> (<year>2010</year>) <volume>32</volume>:<fpage>175</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1016/j.immuni.2010.02.004</pub-id><pub-id pub-id-type="pmid">20189481</pub-id></citation></ref>
<ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Crespo</surname> <given-names>P</given-names></name> <name><surname>Schuebel</surname> <given-names>KE</given-names></name> <name><surname>Ostrom</surname> <given-names>AA</given-names></name> <name><surname>Gutkind</surname> <given-names>JS</given-names></name> <name><surname>Bustelo</surname> <given-names>XR</given-names></name></person-group>. <article-title>Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product</article-title>. <source>Nature</source> (<year>1997</year>) <volume>385</volume>:<fpage>169</fpage>&#x02013;<lpage>72</lpage>.<pub-id pub-id-type="doi">10.1038/385169a0</pub-id><pub-id pub-id-type="pmid">8990121</pub-id></citation></ref>
<ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wiseman</surname> <given-names>JC</given-names></name> <name><surname>Ma</surname> <given-names>LL</given-names></name> <name><surname>Marr</surname> <given-names>KJ</given-names></name> <name><surname>Jones</surname> <given-names>GJ</given-names></name> <name><surname>Mody</surname> <given-names>CH</given-names></name></person-group>. <article-title>Perforin-dependent cryptococcal microbicidal activity in NK cells requires PI3K-dependent ERK1/2 signaling</article-title>. <source>J Immunol</source> (<year>2007</year>) <volume>178</volume>:<fpage>6456</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.178.10.6456</pub-id><pub-id pub-id-type="pmid">17475875</pub-id></citation></ref>
<ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname> <given-names>P</given-names></name> <name><surname>Sang</surname> <given-names>HW</given-names></name> <name><surname>Zhu</surname> <given-names>M</given-names></name></person-group>. <article-title>Critical roles of co-activation receptor DNAX accessory molecule-1 in natural killer cell immunity</article-title>. <source>Immunology</source> (<year>2015</year>) <volume>146</volume>:<fpage>369</fpage>&#x02013;<lpage>78</lpage>.<pub-id pub-id-type="doi">10.1111/imm.12516</pub-id><pub-id pub-id-type="pmid">26235210</pub-id></citation></ref>
<ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Billadeau</surname> <given-names>DD</given-names></name> <name><surname>Upshaw</surname> <given-names>JL</given-names></name> <name><surname>Schoon</surname> <given-names>RA</given-names></name> <name><surname>Dick</surname> <given-names>CJ</given-names></name> <name><surname>Leibson</surname> <given-names>PJ</given-names></name></person-group>. <article-title>NKG2D-DAP10 triggers human NK cell-mediated killing via a Syk-independent regulatory pathway</article-title>. <source>Nat Immunol</source> (<year>2003</year>) <volume>4</volume>:<fpage>557</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1038/ni929</pub-id><pub-id pub-id-type="pmid">12740575</pub-id></citation></ref>
<ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gilfillan</surname> <given-names>S</given-names></name> <name><surname>Ho</surname> <given-names>EL</given-names></name> <name><surname>Cella</surname> <given-names>M</given-names></name> <name><surname>Yokoyama</surname> <given-names>WM</given-names></name> <name><surname>Colonna</surname> <given-names>M</given-names></name></person-group>. <article-title>NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation</article-title>. <source>Nat Immunol</source> (<year>2002</year>) <volume>3</volume>:<fpage>1150</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1038/ni857</pub-id><pub-id pub-id-type="pmid">12426564</pub-id></citation></ref>
<ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Graham</surname> <given-names>DB</given-names></name> <name><surname>Cella</surname> <given-names>M</given-names></name> <name><surname>Giurisato</surname> <given-names>E</given-names></name> <name><surname>Fujikawa</surname> <given-names>K</given-names></name> <name><surname>Miletic</surname> <given-names>AV</given-names></name> <name><surname>Kloeppel</surname> <given-names>T</given-names></name> <etal/></person-group> <article-title>Vav1 controls DAP10-mediated natural cytotoxicity by regulating actin and microtubule dynamics</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>:<fpage>2349</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.177.4.2349</pub-id><pub-id pub-id-type="pmid">16887996</pub-id></citation></ref>
<ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Upshaw</surname> <given-names>JL</given-names></name> <name><surname>Arneson</surname> <given-names>LN</given-names></name> <name><surname>Schoon</surname> <given-names>RA</given-names></name> <name><surname>Dick</surname> <given-names>CJ</given-names></name> <name><surname>Billadeau</surname> <given-names>DD</given-names></name> <name><surname>Leibson</surname> <given-names>PJ</given-names></name></person-group>. <article-title>NKG2D-mediated signaling requires a DAP10-bound Grb2-Vav1 intermediate and phosphatidylinositol-3-kinase in human natural killer cells</article-title>. <source>Nat Immunol</source> (<year>2006</year>) <volume>7</volume>:<fpage>524</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1038/ni1325</pub-id><pub-id pub-id-type="pmid">16582911</pub-id></citation></ref>
<ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oykhman</surname> <given-names>P</given-names></name> <name><surname>Timm-McCann</surname> <given-names>M</given-names></name> <name><surname>Xiang</surname> <given-names>RF</given-names></name> <name><surname>Islam</surname> <given-names>A</given-names></name> <name><surname>Li</surname> <given-names>SS</given-names></name> <name><surname>Stack</surname> <given-names>D</given-names></name> <etal/></person-group> <article-title>Requirement and redundancy of the Src family kinases Fyn and Lyn in perforin-dependent killing of <italic>Cryptococcus neoformans</italic> by NK cells</article-title>. <source>Infect Immun</source> (<year>2013</year>) <volume>81</volume>:<fpage>3912</fpage>&#x02013;<lpage>22</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00533-13</pub-id><pub-id pub-id-type="pmid">23918783</pub-id></citation></ref>
<ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marr</surname> <given-names>KJ</given-names></name> <name><surname>Jones</surname> <given-names>GJ</given-names></name> <name><surname>Zheng</surname> <given-names>C</given-names></name> <name><surname>Huston</surname> <given-names>SM</given-names></name> <name><surname>Timm-McCann</surname> <given-names>M</given-names></name> <name><surname>Islam</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title><italic>Cryptococcus neoformans</italic> directly stimulates perforin production and rearms NK cells for enhanced anticryptococcal microbicidal activity</article-title>. <source>Infect Immun</source> (<year>2009</year>) <volume>77</volume>:<fpage>2436</fpage>&#x02013;<lpage>46</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.01232-08</pub-id><pub-id pub-id-type="pmid">19307209</pub-id></citation></ref>
<ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chester</surname> <given-names>C</given-names></name> <name><surname>Fritsch</surname> <given-names>K</given-names></name> <name><surname>Kohrt</surname> <given-names>HE</given-names></name></person-group>. <article-title>Natural killer cell immunomodulation: targeting activating, inhibitory, and co-stimulatory receptor signaling for cancer immunotherapy</article-title>. <source>Front Immunol</source> (<year>2015</year>) <volume>6</volume>:<fpage>601</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2015.00601</pub-id><pub-id pub-id-type="pmid">26697006</pub-id></citation></ref>
<ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>X</given-names></name> <name><surname>Trivedi</surname> <given-names>PP</given-names></name> <name><surname>Ge</surname> <given-names>B</given-names></name> <name><surname>Krzewski</surname> <given-names>K</given-names></name> <name><surname>Strominger</surname> <given-names>JL</given-names></name></person-group>. <article-title>Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2007</year>) <volume>104</volume>:<fpage>6329</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0611655104</pub-id><pub-id pub-id-type="pmid">17395718</pub-id></citation></ref>
<ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Riteau</surname> <given-names>B</given-names></name> <name><surname>Barber</surname> <given-names>DF</given-names></name> <name><surname>Long</surname> <given-names>EO</given-names></name></person-group>. <article-title>Vav1 phosphorylation is induced by beta2 integrin engagement on natural killer cells upstream of actin cytoskeleton and lipid raft reorganization</article-title>. <source>J Exp Med</source> (<year>2003</year>) <volume>198</volume>:<fpage>469</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20021995</pub-id><pub-id pub-id-type="pmid">12885870</pub-id></citation></ref>
<ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Watzl</surname> <given-names>C</given-names></name> <name><surname>Long</surname> <given-names>EO</given-names></name></person-group>. <article-title>Signal transduction during activation and inhibition of natural killer cells</article-title>. <source>Curr Protoc Immunol</source> (<year>2010</year>) Chapter 11:Unit 11 9B.<pub-id pub-id-type="doi">10.1002/0471142735.im1109bs90</pub-id><pub-id pub-id-type="pmid">20814939</pub-id></citation></ref>
<ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mentlik</surname> <given-names>AN</given-names></name> <name><surname>Sanborn</surname> <given-names>KB</given-names></name> <name><surname>Holzbaur</surname> <given-names>EL</given-names></name> <name><surname>Orange</surname> <given-names>JS</given-names></name></person-group>. <article-title>Rapid lytic granule convergence to the MTOC in natural killer cells is dependent on dynein but not cytolytic commitment</article-title>. <source>Mol Biol Cell</source> (<year>2010</year>) <volume>21</volume>:<fpage>2241</fpage>&#x02013;<lpage>56</lpage>.<pub-id pub-id-type="doi">10.1091/mbc.E09-11-0930</pub-id><pub-id pub-id-type="pmid">20444980</pub-id></citation></ref>
<ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tuli</surname> <given-names>A</given-names></name> <name><surname>Thiery</surname> <given-names>J</given-names></name> <name><surname>James</surname> <given-names>AM</given-names></name> <name><surname>Michelet</surname> <given-names>X</given-names></name> <name><surname>Sharma</surname> <given-names>M</given-names></name> <name><surname>Garg</surname> <given-names>S</given-names></name> <etal/></person-group> <article-title>Arf-like GTPase Arl8b regulates lytic granule polarization and natural killer cell-mediated cytotoxicity</article-title>. <source>Mol Biol Cell</source> (<year>2013</year>) <volume>24</volume>:<fpage>3721</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1091/mbc.E13-05-0259</pub-id><pub-id pub-id-type="pmid">24088571</pub-id></citation></ref>
<ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yi</surname> <given-names>J</given-names></name> <name><surname>Wu</surname> <given-names>X</given-names></name> <name><surname>Chung</surname> <given-names>AH</given-names></name> <name><surname>Chen</surname> <given-names>JK</given-names></name> <name><surname>Kapoor</surname> <given-names>TM</given-names></name> <name><surname>Hammer</surname> <given-names>JA</given-names></name></person-group>. <article-title>Centrosome repositioning in T cells is biphasic and driven by microtubule end-on capture-shrinkage</article-title>. <source>J Cell Biol</source> (<year>2013</year>) <volume>202</volume>:<fpage>779</fpage>&#x02013;<lpage>92</lpage>.<pub-id pub-id-type="doi">10.1083/jcb.201301004</pub-id><pub-id pub-id-type="pmid">23979719</pub-id></citation></ref>
<ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kuhn</surname> <given-names>JR</given-names></name> <name><surname>Poenie</surname> <given-names>M</given-names></name></person-group>. <article-title>Dynamic polarization of the microtubule cytoskeleton during CTL-mediated killing</article-title>. <source>Immunity</source> (<year>2002</year>) <volume>16</volume>:<fpage>111</fpage>&#x02013;<lpage>21</lpage>.<pub-id pub-id-type="doi">10.1016/S1074-7613(02)00262-5</pub-id><pub-id pub-id-type="pmid">11825570</pub-id></citation></ref>
<ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sanborn</surname> <given-names>KB</given-names></name> <name><surname>Rak</surname> <given-names>GD</given-names></name> <name><surname>Maru</surname> <given-names>SY</given-names></name> <name><surname>Demers</surname> <given-names>K</given-names></name> <name><surname>Difeo</surname> <given-names>A</given-names></name> <name><surname>Martignetti</surname> <given-names>JA</given-names></name> <etal/></person-group> <article-title>Myosin IIA associates with NK cell lytic granules to enable their interaction with F-actin and function at the immunological synapse</article-title>. <source>J Immunol</source> (<year>2009</year>) <volume>182</volume>:<fpage>6969</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.0804337</pub-id><pub-id pub-id-type="pmid">19454694</pub-id></citation></ref>
<ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rak</surname> <given-names>GD</given-names></name> <name><surname>Mace</surname> <given-names>EM</given-names></name> <name><surname>Banerjee</surname> <given-names>PP</given-names></name> <name><surname>Svitkina</surname> <given-names>T</given-names></name> <name><surname>Orange</surname> <given-names>JS</given-names></name></person-group>. <article-title>Natural killer cell lytic granule secretion occurs through a pervasive actin network at the immune synapse</article-title>. <source>PLoS Biol</source> (<year>2011</year>) <volume>9</volume>:<fpage>e1001151</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pbio.1001151</pub-id><pub-id pub-id-type="pmid">21931536</pub-id></citation></ref>
<ref id="B53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>James</surname> <given-names>AM</given-names></name> <name><surname>Hsu</surname> <given-names>HT</given-names></name> <name><surname>Dongre</surname> <given-names>P</given-names></name> <name><surname>Uzel</surname> <given-names>G</given-names></name> <name><surname>Mace</surname> <given-names>EM</given-names></name> <name><surname>Banerjee</surname> <given-names>PP</given-names></name> <etal/></person-group> <article-title>Rapid activation receptor- or IL-2-induced lytic granule convergence in human natural killer cells requires Src, but not downstream signaling</article-title>. <source>Blood</source> (<year>2013</year>) <volume>121</volume>:<fpage>2627</fpage>&#x02013;<lpage>37</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2012-06-437012</pub-id></citation></ref>
<ref id="B54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hidore</surname> <given-names>MR</given-names></name> <name><surname>Mislan</surname> <given-names>TW</given-names></name> <name><surname>Murphy</surname> <given-names>JW</given-names></name></person-group>. <article-title>Responses of murine natural killer cells to binding of the fungal target <italic>Cryptococcus neoformans</italic></article-title>. <source>Infect Immun</source> (<year>1991</year>) <volume>59</volume>:<fpage>1489</fpage>&#x02013;<lpage>99</lpage>.<pub-id pub-id-type="pmid">2004827</pub-id></citation></ref>
<ref id="B55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kyei</surname> <given-names>SK</given-names></name> <name><surname>Ogbomo</surname> <given-names>H</given-names></name> <name><surname>Li</surname> <given-names>S</given-names></name> <name><surname>Timm-McCann</surname> <given-names>M</given-names></name> <name><surname>Xiang</surname> <given-names>RF</given-names></name> <name><surname>Huston</surname> <given-names>SM</given-names></name> <etal/></person-group> <article-title>Mechanisms by which interleukin-12 corrects defective NK cell anticryptococcal activity in HIV-infected patients</article-title>. <source>MBio</source> (<year>2016</year>) <volume>7</volume>.<pub-id pub-id-type="doi">10.1128/mBio.00878-16</pub-id></citation></ref>
<ref id="B56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sawadogo</surname> <given-names>S</given-names></name> <name><surname>Makumbi</surname> <given-names>B</given-names></name> <name><surname>Purfield</surname> <given-names>A</given-names></name> <name><surname>Ndjavera</surname> <given-names>C</given-names></name> <name><surname>Mutandi</surname> <given-names>G</given-names></name> <name><surname>Maher</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>Estimated prevalence of <italic>Cryptococcus</italic> antigenemia (CrAg) among HIV-infected adults with advanced immunosuppression in Namibia justifies routine screening and preemptive treatment</article-title>. <source>PLoS One</source> (<year>2016</year>) <volume>11</volume>:<fpage>e0161830</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0161830</pub-id><pub-id pub-id-type="pmid">27760140</pub-id></citation></ref>
<ref id="B57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fraison</surname> <given-names>JB</given-names></name> <name><surname>Guilpain</surname> <given-names>P</given-names></name> <name><surname>Schiffmann</surname> <given-names>A</given-names></name> <name><surname>Veyrac</surname> <given-names>M</given-names></name> <name><surname>Le Moing</surname> <given-names>V</given-names></name> <name><surname>Rispail</surname> <given-names>P</given-names></name> <etal/></person-group> <article-title>Pulmonary cryptococcosis in a patient with Crohn&#x02019;s disease treated with prednisone, azathioprine and adalimumab: exposure to chicken manure as a source of contamination</article-title>. <source>J Crohns Colitis</source> (<year>2013</year>) <volume>7</volume>:<fpage>e11</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1016/j.crohns.2012.04.016</pub-id><pub-id pub-id-type="pmid">22647638</pub-id></citation></ref>
<ref id="B58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sethi</surname> <given-names>NK</given-names></name> <name><surname>Torgovnick</surname> <given-names>J</given-names></name> <name><surname>Sethi</surname> <given-names>PK</given-names></name></person-group>. <article-title>Cryptococcal meningitis after imuran (azathioprine) therapy for autoimmune hepatitis</article-title>. <source>Eur J Gastroenterol Hepatol</source> (<year>2007</year>) <volume>19</volume>:<fpage>913</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="doi">10.1097/MEG.0b013e3282cf4ed9</pub-id></citation></ref>
<ref id="B59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Neurath</surname> <given-names>M</given-names></name></person-group>. <article-title>Thiopurines in IBD: what is their mechanism of action?</article-title> <source>Gastroenterol Hepatol (N Y)</source> (<year>2010</year>) <volume>6</volume>:<fpage>435</fpage>&#x02013;<lpage>6</lpage>.</citation></ref>
<ref id="B60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tiede</surname> <given-names>I</given-names></name> <name><surname>Fritz</surname> <given-names>G</given-names></name> <name><surname>Strand</surname> <given-names>S</given-names></name> <name><surname>Poppe</surname> <given-names>D</given-names></name> <name><surname>Dvorsky</surname> <given-names>R</given-names></name> <name><surname>Strand</surname> <given-names>D</given-names></name> <etal/></person-group> <article-title>CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4&#x0002B; T lymphocytes</article-title>. <source>J Clin Invest</source> (<year>2003</year>) <volume>111</volume>:<fpage>1133</fpage>&#x02013;<lpage>45</lpage>.<pub-id pub-id-type="doi">10.1172/JCI16432</pub-id><pub-id pub-id-type="pmid">12697733</pub-id></citation></ref>
</ref-list>
</back>
</article>